Stoke Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Stoke Therapeutics

06/11/2024 04:53

* Stoke Therapeutics Inc  STOK.OQ  reported a quarterly
adjusted
loss of 47 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -55 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 53 cents per
share. Wall Street expected results to range from -60 cents
to -49 cents per share.
    * Revenue rose 47.9% to $4.89 million from a year ago;
analysts
expected $3.35 million. 
    * Stoke Therapeutics Inc's reported EPS for the quarter was
a loss
of 47 cents​.
    * The company reported a quarterly loss of $26.43 million.
    * Stoke Therapeutics Inc shares had risen by 6.6% this
quarter and
gained 149.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Stoke
Therapeutics Inc is $20.00 
This summary was machine generated from LSEG data November 6 at
04:53 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.53          -0.47          Beat
 Jun. 30 2024      -0.56          -0.46          Beat
 Mar. 31 2024      -0.61          -0.57          Beat
 Dec. 31 2023      -0.63          -0.60          Beat